MedPath

烟台正方制药有限公司

Ownership
-
Established
2006-08-23
Employees
-
Market Cap
-
Website
http://www.ytzhengfang.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

5

NMPA:5

Drug Approvals

Mitiglinide calcium

Product Name
米格列奈钙
Approval Number
国药准字H20153268
Approval Date
Apr 10, 2024
NMPA

益心酮分散片

Approval Number
国药准字Z20090717
Approval Date
Sep 4, 2023
NMPA

复肝宁胶囊

Approval Number
国药准字Z20090725
Approval Date
Jul 25, 2023
NMPA

Pioglitazone Hydrochloride Tablets

Product Name
盐酸吡格列酮片
Approval Number
国药准字H20070229
Approval Date
Mar 18, 2022
NMPA

Mitiglinide Calcium Capsules

Product Name
米格列奈钙胶囊
Approval Number
国药准字H20153263
Approval Date
Jul 30, 2020
NMPA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.